Review Article

Cryptococcosis in Hematopoietic Stem Cell Transplant Recipients: A Rare Presentation Warranting Recognition

Table 2

Demographic and clinical characteristics of hematopoietic stem cell transplant recipients with cryptococcosis and characteristics of the disease.

CharacteristicNumber (%)

Gender (n = 17)
 Male9 (52.9)
 Female8 (47.1)
Primary hematologic disease (n = 16)
 Multiple myeloma4 (25.0)
 Acute myelogenous leukemia3 (18.8)
 Acute lymphoblastic leukemia2 (12.5)
 Peripheral T-cell lymphoma2 (12.5)
 Diffuse large B-cell lymphoma1 (6.3)
 Follicular lymphoma1 (6.3)
 Hodgkin’s lymphoma1 (6.3)
 Myelodysplastic syndrome1 (6.3)
 Unspecified leukemia1 (6.3)
Transplant type (n = 22)
 Allogeneic11 (50.0)
 Autologous11 (50.0)
Site of infection (n = 23)
 CNS12 (52.2)
 Cryptococcemia4 (17.4)
 Disseminated3 (13.0)
 Pulmonary2 (8.7)
 Other2 (8.7)
Outcome (n = 20)
 Dead10 (50.0)
 Alive10 (50.0)
Species (n = 21)
Cryptococcus neoformans13 (61.9)
Cryptococcus laurentii3 (14.3)
Cryptococcus sp.2 (9.5)
Cryptococcus adeliensis1 (4.8)
Cryptococcus albidus1 (4.8)
Cryptococcus terreus1 (4.8)
Median (range)
Age (years) (n = 17)47 (12–74)
Time of onset after HSCT (days) (n = 20)57.5 (0–1825)

n, number of cases with available data from the patients.